Subtle progesterone rise on the day of human chorionic gonadotropin administration is associated with lower live birth rates in women undergoing assisted reproductive technology: a retrospective study with 2,555 fresh embryo transfers
Robert Ochsenkühn, Andrea Arzberger, Viktoria von Schönfeldt, Julia Gallwas, Nina Rogenhofer, Alexander Crispin, Christian J Thaler, Ulrich Noss, Robert Ochsenkühn, Andrea Arzberger, Viktoria von Schönfeldt, Julia Gallwas, Nina Rogenhofer, Alexander Crispin, Christian J Thaler, Ulrich Noss
Abstract
Objective: To evaluate the association between serum P levels on the day of hCG administration and pregnancy outcome in women undergoing controlled ovarian hyperstimulation, prevention of premature ovulation by GnRH analogues, and fresh ET after 5 days of embryo culture.
Design: Retrospective, observational, cohort study.
Setting: Private IVF center.
Patient(s): A total of 2,555 women undergoing fresh ET on day 5 in 2,062 GnRH agonist and 493 GnRH antagonist cycles.
Intervention(s): None.
Main outcome measure(s): Live birth rate.
Result(s): Live birth rate in cycles with GnRH agonists was significantly lower in women with P levels ≥ 2.0 ng/mL (17.4%) on the day of hCG administration as compared with women with P levels <1.5 ng/mL (24.6%) and 1.5-1.99 ng/mL (26.7%). No such significant differences in live birth rates in cycles with GnRH antagonist could be observed.
Conclusion(s): A rise of serum P levels ≥ 2.0 ng/mL on the day of hCG administration is associated with impaired early embryo implantation and reduced live birth rate in cycles with GnRH agonists after day-5 fresh ET.
Trial registration: ClinicalTrials.gov NCT01426152.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Source: PubMed